Journal of Jilin University(Medicine Edition) ›› 2024, Vol. 50 ›› Issue (1): 88-96.doi: 10.13481/j.1671-587X.20240111
• Research in basic medicine • Previous Articles Next Articles
Received:2023-04-11
Online:2024-01-28
Published:2024-01-31
Contact:
Zhongxin FENG
E-mail:fengsuyan2006@126.com
CLC Number:
Zhongxin FENG,Mei LI. Effect of soluble CD40 ligand on biological behavior of THP-1 cells through long non-coding RNA linc00239[J].Journal of Jilin University(Medicine Edition), 2024, 50(1): 88-96.
Tab. 2
Expression levels of Bcl-2 and Bax mRNA in cells in various groups"
| Group | Bcl-2 mRNA | Bax mRNA |
|---|---|---|
| Control | 1.00±0.05 | 1.00±0.03 |
| Vector | 1.00±0.04 | 1.17±0.08 |
| PcDNA-linc00239 | 1.80±0.06* | 0.17±0.01* |
| Sh-linc00239 | 0.26±0.04* | 5.18±0.44* |
| Vector+CD40L | 0.22±0.01* | 3.70±0.24* |
| PcDNA-linc00239+CD40L | 0.46±0.03△ | 2.07±0.12△ |
| Sh-linc00239+CD40L | 0.05±0.01# | 7.52±0.14# |
| 1 | NEWELL L F, COOK R J. Advances in acute myeloid leukemia[J]. BMJ, 2021, 375: n2026. |
| 2 | DINARDO C, LACHOWIEZ C. Acute myeloid leukemia: from mutation profiling to treatment decisions[J].Curr Hematol Malig Rep,2019,14(5): 386-394. |
| 3 | TAKAMI A. Hematopoietic stem cell transplantation for acute myeloid leukemia[J].Int J Hematol,2018,107(5): 513-518. |
| 4 | KARNELL J L, RIEDER S A, ETTINGER R, et al. Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond[J]. Adv Drug Deliv Rev, 2019, 141: 92-103. |
| 5 | 封忠昕, 陈 琦, 王永伦, 等. 可溶性CD40配体对白血病HL-60细胞Caspase-3及Caspase-8表达的影响[J]. 中华肿瘤防治杂志, 2016, 23(19): 1287-1290. |
| 6 | 封忠昕, 陈 琦, 闵 迅, 等. 可溶性CD40配体对白血病THP-1细胞的影响及机制[J]. 中国老年学杂志, 2018, 38(14): 3472-3474. |
| 7 | FENG Z X, CHEN Q, REN M Q, et al. CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway[J]. Onco Targets Ther, 2019, 12: 3011-3017. |
| 8 | FENG Z X, CHEN Q. Raised CD40L expression attenuates drug resistance in Adriamycin-resistant THP-1 cells[J].Exp Ther Med,2020,19(3):2188-2194. |
| 9 | YANG Y T, DAI W S, SUN Y W, et al. Long non‑coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells[J]. Oncol Rep, 2019, 41(4): 2311-2320. |
| 10 | 封忠昕, 陈 琦, 王季石, 等. 可溶性CD40配体对白血病THP-1细胞生物学影响及机制研究[J]. 中华肿瘤防治杂志, 2019, 26(10): 690-694. |
| 11 | SAUER T, ROONEY C M. Current challenges for CAR T-cell therapy of acute myeloid leukemia[J]. Transfusion, 2019, 59(4): 1171-1173. |
| 12 | LIN W Y, ZHOU Q Y, WANG C Q, et al. LncRNAs regulate metabolism in cancer[J]. Int J Biol Sci, 2020, 16(7): 1194-1206. |
| 13 | PENG W X, KOIRALA P, MO Y Y. LncRNA-mediated regulation of cell signaling in cancer[J]. Oncogene, 2017, 36(41): 5661-5667. |
| 14 | DONJERKOVIC D, SCOTT D W. Regulation of the G1 phase of the mammalian cell cycle[J]. Cell Res, 2000, 10(1): 1-16. |
| 15 | YANG R, DONG H, JIA S, et al. Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy[J]. Clin Transl Oncol, 2022, 24(7):1219-1230. |
| 16 | DAS S, SHUKLA N, SINGH S S, et al. Mechanism of interaction between autophagy and apoptosis in cancer[J]. Apoptosis, 2021, 26(9/10): 512-533. |
| 17 | RAHMANI M, NKWOCHA J, HAWKINS E, et al. Cotargeting BCL-2 and PI3K induces BAX-dependent mitochondrial apoptosis in AML cells[J]. Cancer Res, 2018, 78(11): 3075-3086. |
| 18 | EDLICH F. BCL-2 proteins and apoptosis: recent insights and unknowns[J]. Biochem Biophys Res Commun, 2018, 500(1): 26-34. |
| 19 | LIU L, YANG L, LIU X J, et al. SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling[J]. J Transl Med, 2022, 20(1): 304. |
| 20 | LIU H C, HUSSAIN Z, XIE Q Q, et al. Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax[J]. Exp Cell Res, 2022, 417(2): 113192. |
| 21 | NOOROLYAI S, SHAJARI N, BAGHBANI E, et al. The relation between PI3K/AKT signalling pathway and cancer[J]. Gene, 2019, 698: 120-128. |
| 22 | 张 靖, 冯晓杰, 白惠娟. lncRNA PTPRG-AS1通过调控PI3K/Akt信号通路对卵巢癌细胞增殖和凋亡的影响[J].郑州大学学报(医学版),2021,56(2):275-279. |
| [1] | Yang LI,Shiyang LI,Hongmei ZHANG,Qianqian LIU,Yubing CHEN. Effect of NGFR gene expression differences on promotion of apoptosis of squamous cell carcinoma and adenocarcinoma cells by PD-1 inhibitor-activated T lymphocytes [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 680-693. |
| [2] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [3] | Zhipeng PAN,Le WANG,Weiwen HUANG,Zhen YI,Yuxuan GAO. Bioinformatics analysis and experimental validation based on screening and identification of diagnostic candidate genes of bone marrow mononuclear cells of acute myeloid leukemia patients and their impact on prognosis [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 791-805. |
| [4] | Qiuping SU,Lei XING,Wei ZHANG,Shan JIANG,Yangyang ZHAO,Fangfang CHEN. Research progress in anti-tumor mechanism of berberine and application of its novel nano-delivery system in tumor therapy [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 863-871. |
| [5] | Jie YU,Zongkang WANG,Xun LIU,Yanan YANG,Jin TAN. Effect of miR-153-3p/PGC-1α axis on apoptosis of oral squamous cell carcinoma cells by modulation of mitochondrial apoptosis pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 348-358. |
| [6] | Yu ZHAO,Xiaoshuang HE,Xiaoyin DONG,Fengyi GAO,Jiageng HE. Regulatory effect of lncRNA urothelial carcinoembryonic antigen 1 on anoikis in human gastrointestinal stromal tumor cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 429-439. |
| [7] | Yaping LI,Chunyan TAN,Lujie ZHAO,Jiayi ZHAO,Ting LI,Xiao YANG,Xiaoyun YANG. Inductive effect of lysophosphatidic acid combined with 6-hydroxydopamine on apoptosis of SH-SY5Y cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 152-161. |
| [8] | Jiaxin WANG,Junwen MAO,Xuan ZHANG. Expression of natural autoantibodies against apoptosis inhibitory genes in plasma of patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 228-235. |
| [9] | Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG. UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69. |
| [10] | Shanshan SUN,Mei LU,Xinfu GAO,LYu Guangyao,Baolei Zhao,LYu Wenwen. Inhibitory effect of Bradykinin 1 receptor antagonist ELN441958 on proliferation of HepG2 cells by regulating Akt/FoxO3a signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 70-80. |
| [11] | Xiaohan YAO,Mingchen YAO,Zhiqing WANG,Heyang LI,Yan YAN,Ningjing LEI. Effect of silencing GPR139 gene on proliferation, apoptosis and autophagy of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 1-9. |
| [12] | Dayou DAI,Zhigang ZHANG,Hui LI. Effect of CHRNA5 in occurrence and development of pancreas cancer and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1518-1531. |
| [13] | Han XUE,Yuxin FAN,Ting ZHANG,Zhimin LI,Mingge HUO,Xingang GUAN. Preparation of nanodrug PTX2 NPs and its killing effect on human lung cancer A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1260-1266. |
| [14] | Wenxuan LI,Minru ZONG. Research progress in role of migration of Schwann cells in repairment of peripheral nerve injury [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1137-1144. |
| [15] | Jiarui LI,Zhenlin YANG,Fan GAO,Jingjing GUO,Jinzi LI. Effect of miR-34a-5p on hippocampal neuron apoptosis in rats with temporal lobe epilepsy and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 939-947. |
|
